Felipe A, Valdes R, Santo B, Lloberas J, Casado J, Pastor-Anglada M
Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, 08071 Barcelona, Spain.
Biochem J. 1998 Mar 1;330 ( Pt 2)(Pt 2):997-1001. doi: 10.1042/bj3300997.
Hepatocytes show a Na+-dependent nucleoside transport activity that is kinetically heterogeneous and consistent with the expression of at least two independent concentrative Na+-coupled nucleoside transport systems (Mercader et al. Biochem. J. 317, 835-842, 1996). So far, only a single nucleoside carrier-related cDNA (SPNT) has been isolated from liver cells (Che et al. J. Biol. Chem. 270, 13596-13599, 1995). This cDNA presumably encodes a plasma membrane protein responsible for Na+-dependent purine nucleoside transport activity. Thus, the liver must express, at least, a second nucleoside transporter which should be pyrimidine-preferring. Homology cloning using RT-PCR revealed that a second isoform is indeed present in liver. This second isoform turned out to be identical to the 'epithelial-specific isoform' called cNT1, which shows in fact high specificity for pyrimidine nucleosides. Although cNT1 mRNA is present at lower amounts than SPNT mRNA, the amounts of cNT1 protein, when measured using isoform-specific polyclonal antibodies, were even higher than the SPNT protein levels. Moreover, partially purified basolateral plasma membrane vesicles from liver were enriched in the SPNT but not in the cNT1 protein, which suggests that the subcellular localization of these carrier proteins is different. SPNT and cNT1 protein amounts in crude membrane extracts from 6 h-regenerating rat livers are higher than in the preparations from sham-operated controls (3.5- and 2-fold, respectively). These results suggest that liver parenchymal cells express at least two different isoforms of concentrative nucleoside carriers, the cNT1 and SPNT proteins, which show differential regulation and subcellular localization.
肝细胞表现出一种钠依赖性核苷转运活性,其动力学具有异质性,且与至少两种独立的钠偶联核苷浓缩转运系统的表达一致(梅尔卡德等人,《生物化学杂志》317卷,835 - 842页,1996年)。到目前为止,仅从肝细胞中分离出一种与核苷载体相关的cDNA(SPNT)(车等人,《生物化学杂志》270卷,13596 - 13599页,1995年)。该cDNA可能编码一种负责钠依赖性嘌呤核苷转运活性的质膜蛋白。因此,肝脏必定至少表达第二种核苷转运体,它应该更倾向于转运嘧啶核苷。利用逆转录聚合酶链反应(RT-PCR)进行的同源克隆显示,肝脏中确实存在第二种异构体。结果表明,这种第二种异构体与被称为cNT1的“上皮特异性异构体”相同,实际上它对嘧啶核苷具有高度特异性。尽管cNT1 mRNA的含量低于SPNT mRNA,但使用异构体特异性多克隆抗体检测时,cNT1蛋白的含量甚至高于SPNT蛋白水平。此外,从肝脏中部分纯化的基底外侧质膜囊泡富含SPNT蛋白,但不富含cNT1蛋白,这表明这些载体蛋白的亚细胞定位不同。来自6小时再生大鼠肝脏的粗膜提取物中SPNT和cNT1蛋白的含量高于假手术对照组的提取物(分别为3.5倍和2倍)。这些结果表明,肝实质细胞表达至少两种不同的核苷浓缩载体异构体,即cNT1和SPNT蛋白,它们表现出不同的调控方式和亚细胞定位。